NORMAL SITUATION

PHARMA WANDRE

Export PDF

Financial year 2021 · closed on 31/12/2021

Net result

144 k €

+134.5% YoY

Revenue

1,8 M €

Equity

538,6 k €

+36.5% YoY

Workforce

4,4 ETP

+100.0% YoY

Company — Normal situation.

What does PHARMA WANDRE do?

PHARMA WANDRE is a company registered in Belgium. It employs on average 4,4 ETP workers (FTE).

Legal situation

● Normal situation

BCE/KBO no. / VAT

BE 0466.169.231

Legal form

Private company with limited liability

Contributed capital

12 397,34 €

Latest accounts

31/12/2021

Average workforce

4,4 ETP

Joint committees (1)

Signals

ProfitableSolid equityGood liquidityPositive cashflowPositive EBITDAHealthy social debts

View the BCE/KBO Public Search record →

Health score

Available with a Rovalta subscriptionTry for 7 days

Recommended credit limit

✦ Verdict · Analyst summary

Financials

Trend over 13 financial years

	2021		2020		2019		2018		2017		2016		2015		2014		2013		2012		2011		2010		2009
Income statement
Revenue	1,8 M €		–		–		–		–		–		–		–		–		–		–		–		–
EBITDA	211,1 k €	+92.3%	109,8 k €	+6.1%	103,5 k €	+29.7%	79,8 k €	+2.4%	78 k €	-49.7%	154,9 k €	+12.6%	137,6 k €	-12.3%	157 k €	+14.0%	137,7 k €	-28.8%	193,4 k €	-8.3%	210,9 k €	-12.9%	242,1 k €	-2.8%	249 k €
Operating result	199,3 k €	+92.6%	103,5 k €	+150%	41,4 k €	-27.3%	57 k €	-1.9%	58,1 k €	-46.1%	107,8 k €	+8.8%	99,1 k €	+3.0%	96,2 k €	+18.1%	81,4 k €	+51.5%	53,7 k €	-42.5%	93,4 k €	+2.9%	90,7 k €	+3.1%	88 k €
Net result	144 k €	+134%	61,4 k €	+76.8%	34,7 k €	+8.5%	32 k €	+794%	3,6 k €	-94.6%	66,7 k €	+19.5%	55,8 k €	+8.0%	51,6 k €	+47.5%	35 k €	+664%	4,6 k €	-87.1%	35,6 k €	+18.1%	30,2 k €	+97.7%	15,3 k €
Balance sheet
Equity	538,6 k €	+36.5%	394,5 k €	+18.4%	333,1 k €	+11.6%	298,4 k €	+12.0%	266,4 k €	+1.4%	262,8 k €	+34.0%	196,1 k €	+39.7%	140,4 k €	-41.6%	240,3 k €	-41.1%	408,3 k €	+1.1%	403,7 k €	+9.7%	368,1 k €	+8.9%	338 k €
Total assets	833,8 k €	+52.1%	548,1 k €	-17.0%	660 k €	-9.0%	725 k €	-25.2%	969,7 k €	+2.6%	945,1 k €	+10.5%	855 k €	-27.0%	1,2 M €	-7.3%	1,3 M €	-15.1%	1,5 M €	-23.0%	1,9 M €	+3.2%	1,9 M €	+1.6%	1,8 M €
Cash	137 k €	+227%	42 k €	-62.9%	113 k €	-21.6%	144,2 k €	-48.3%	279 k €	+37.1%	203,4 k €	+329%	47,4 k €	-80.8%	247,1 k €	+51.8%	162,7 k €	+22.1%	133,3 k €	-46.1%	247,4 k €	+24.8%	198,2 k €	+29.4%	153,1 k €
Debts	295,3 k €	+92.3%	153,6 k €	-48.0%	295,4 k €	-14.7%	346,4 k €	-46.1%	642,6 k €	+1.4%	633,7 k €	+3.8%	610,5 k €	-37.9%	982,5 k €	-2.4%	1 M €	-5.2%	1,1 M €	-29.2%	1,5 M €	+0.9%	1,5 M €	-0.2%	1,5 M €
Other
Workforce	4,4 ETP	+100%	2,2 ETP	-4.3%	2,3 ETP		–		2,1 ETP	+110%	1,0 ETP	0.0%	1,0 ETP	0.0%	1,0 ETP	-63.0%	2,7 ETP	-3.6%	2,8 ETP	+7.7%	2,6 ETP	+44.4%	1,8 ETP	0.0%	1,8 ETP

Governance

Board of directors

Seen on filing of 31/12/2021 · 1 active · 3 ended

Active mandates

PEETERS PHARMA

Mandate · 0888.243.054

Represented by Mathieu Peeters

Active

Ended mandates

Corinne Blistin

Mandate

Ended

Corinne Blistin

Manager

Ended

Corrine Blistin

Manager

Ended

Annual accounts

Full financial information

	2021	2020	2019	2018	2017	2016
Type of account	Abridged model	Abridged model	Abridged model	Abridged model	Abridged model	Abridged model
Start of the financial year	01/01/2021	01/01/2020	01/01/2019	01/01/2018	01/01/2017	01/01/2016
Closing of the financial year	31/12/2021	31/12/2020	31/12/2019	31/12/2018	31/12/2017	31/12/2016
Length of the financial year	12 months	12 months	12 months	12 months	12 months	12 months
Filing date	29/06/2022	30/07/2021	22/12/2020	29/08/2019	30/08/2018	30/08/2017
General meeting	14/06/2022	07/07/2021	09/06/2020	11/06/2019	12/06/2018	13/06/2017
Currency of the financial year	EUR	EUR	EUR	EUR	EUR	EUR
NBB quality label	Satisfying controls	Satisfying controls	Satisfying controls	Satisfying controls	Satisfying controls	Satisfying controls

Ratios

Financial ratios

Looking for more information about this company?

Try for 7 days

Filings

Annual accounts filings

22 filings with the NBB

Model	Closing	General meeting	Filed	Language	Document
Abridged model	31/12/2021	14/06/2022	29/06/2022	French	PDF
Abridged model	31/12/2020	07/07/2021	30/07/2021	Dutch	PDF
Abridged model	31/12/2019	09/06/2020	22/12/2020	French	PDF
Abridged model	31/12/2018	11/06/2019	29/08/2019	French	PDF
Abridged model	31/12/2017	12/06/2018	30/08/2018	French	PDF
Abridged model	31/12/2016	13/06/2017	30/08/2017	Dutch	PDF
Abridged model	31/12/2015	14/06/2016	31/08/2016	French	PDF
Abridged model	31/12/2014	09/06/2015	27/08/2015	Dutch	PDF
Abridged model	31/12/2013	10/06/2014	27/08/2014	French	PDF
Abridged model	31/12/2012	11/06/2013	29/08/2013	French	PDF
Abridged model	31/12/2011	12/06/2012	30/08/2012	French	PDF
Abridged model	31/12/2010	14/06/2011	31/08/2011	French	PDF
Abridged model	31/12/2009	08/06/2010	26/08/2010	French	PDF
Abridged model	31/12/2008	02/06/2009	01/07/2009	French	PDF
Abridged model	31/12/2007	03/06/2008	20/08/2008	French	PDF
Abridged model	31/12/2006	05/06/2007	24/08/2007	French	PDF
Abridged model	31/12/2005	06/06/2006	29/08/2006	French	PDF
Abridged model	31/12/2004	07/06/2005	30/09/2005	French	PDF
Abridged model	31/12/2003	08/06/2004	20/08/2004	French	PDF
Abridged model	31/12/2002	10/06/2003	26/09/2003	French	PDF
Abridged model	31/12/2001	11/06/2002	17/09/2002	French	PDF
Abridged model	31/12/2000	12/06/2001	28/09/2001	French	PDF

Estimate

Indicative valuation

The detail comes with the Business plan: low and high bounds, the valuation bridge for each financial year, transaction multiples by sector and size, group valuation and exports.

Discover the Business plan

Disclaimer

Indicative estimate based on public sector multiples and the filed annual accounts. It is neither a certified valuation nor financial or investment advice.

Governance

Board of directors

Seen on filing of 31/12/2021 · 1 active · 3 ended

Active mandates

PEETERS PHARMA

Mandate · 0888.243.054

Represented by Mathieu Peeters

Active

Ended mandates

Corinne Blistin

Mandate

Ended

Corinne Blistin

Manager

Ended

Corrine Blistin

Manager

Ended

Shareholders

Ownership and network

Looking for more information about this company?

Try for 7 days

Competition

Similar companies

A company's peers, by sector and size, are included in the Business plan.

See the Business plan

2021
Annual accounts 2021144 k €↑
2020
Annual accounts 202061,4 k €↑
2019
Annual accounts 201934,7 k €↑
2018
Annual accounts 201832 k €↑
2017
Annual accounts 20173,6 k €↓
2016
Annual accounts 201666,7 k €↑
2015
Annual accounts 201555,8 k €↑
2014
Annual accounts 201451,6 k €↑
2013
Annual accounts 201335 k €↑
2012
Annual accounts 20124,6 k €↓
2011
Annual accounts 201135,6 k €↑
2010
Annual accounts 201030,2 k €↑
2009
Annual accounts 200915,3 k €

10/15	1 240 000	1 180 000	1 050 000
70	8 630 000	8 120 000	7 940 000
9904	412 000	388 000	301 000
17/49	2 970 000	3 140 000	3 380 000
9087	24,3	23,1	21,8

PHARMA WANDRE

Overview

What does PHARMA WANDRE do?

Trend over 13 financial years

Board of directors

Financials

Full financial information

Financial ratios

Annual accounts filings

Valuation

Indicative valuation

Directors & structure

Board of directors

Ownership and network

Publications

Similar companies

Similar companies

Timeline